Anthony J. Olszanski
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 51
- CAR-T cell therapy research 39
- Cancer Treatment and Pharmacology 19
- Biological Psychiatry top 2%
- Immunology top 2%
- Immunotherapy and Immune Responses 14
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 11
-
- Lung Cancer Treatments and Mutations 26
-
- Melanoma and MAPK Pathways 24
-
- Cancer Research and Treatments 11
Anthony J. Olszanski
148 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 2.6k
- Biological Psychiatry 218
- Immunology 1.3k
- Cancer Research 443
- Pulmonary and Respiratory Medicine 848
Countries citing papers authored by Anthony J. Olszanski
This map shows the geographic impact of Anthony J. Olszanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony J. Olszanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony J. Olszanski more than expected).
Fields of papers citing papers by Anthony J. Olszanski
This network shows the impact of papers produced by Anthony J. Olszanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony J. Olszanski. The network helps show where Anthony J. Olszanski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anthony J. Olszanski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 24 | |
| 8 | 2023 | 5 | |
| 9 | 2021 | 10 | |
| 10 | 2020 | 4 | |
| 11 | 2020 | 58 | |
| 12 | 2017 | 157 | |
| 13 | 2017 | 36 | |
| 14 | 2014 | 5 | |
| 15 | 2013 | 28 | |
| 16 | 2013 | 30 | |
| 17 | 2012 | 24 | |
| 18 | 2010 | 15 | |
| 19 | Axitinib (AG-013736; AG) in combination with paclitaxel (P)/carboplatin (C) in patients (pts) with advanced solid tumors | 2007 | 1 |
| 20 | 1991 | 1 |
About Anthony J. Olszanski
Anthony J. Olszanski is a scholar working on Oncology, Biological Psychiatry and Pulmonary and Respiratory Medicine, having authored 156 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (51 papers), CAR-T cell therapy research (39 papers), Lung Cancer Treatments and Mutations (26 papers), Melanoma and MAPK Pathways (24 papers), Cancer Treatment and Pharmacology (19 papers), Immunotherapy and Immune Responses (14 papers), Cancer Genomics and Diagnostics (11 papers) and Cancer Research and Treatments (11 papers). The work is most often cited by research in Oncology (2.6k citations), Biological Psychiatry (218 citations) and Immunology (1.3k citations). Anthony J. Olszanski has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Thomas F. Gajewski, Ari M. Vanderwalde, Igor Puzanov, Jonathan Cebon, Lisa Chen, Antoni Ribas, Reinhard Dummer, John M. Kirkwood, F. Stephen Hodi and Georgina V. Long. Their work appears in journals such as New England Journal of Medicine, Cell and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.